BackZhongzhi Pharmaceutical Holdings Limited Overview

Zhongzhi Pharmaceutical Holdings Limited Inventory

Track Zhongzhi Pharmaceutical Holdings Limited's inventory ($240M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$241.51M
↓ 20.06% YoYΔ $-60.61M vs prior year quarter

Peer trimmed avg / median

Loading

Zhongzhi Pharmaceutical Holdings Limited Inventory History

Loading

Zhongzhi Pharmaceutical Holdings Limited vs. peers: Inventory Comparison

Loading

Zhongzhi Pharmaceutical Holdings Limited Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Zhongzhi Pharmaceutical Holdings Limited (3737.HK) FAQ

As of the most recent data (June 2026), 3737.HK shows a inventory of $240M. That compares with $300M in the prior-year period — down 20.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 3737.HK's inventory is now $240M (was $300M) — a 20.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Zhongzhi Pharmaceutical Holdings Limited is outperforming or lagging.

Tracking 3737.HK's inventory over time shows whether Zhongzhi Pharmaceutical Holdings Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $240M That compares with $300M in the prior-year period — down 20.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Zhongzhi Pharmaceutical Holdings Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $240M) with ownership activity and broader fundamentals.